MHC Class II Presentation – Function and Importance
MHC class II presentation is a key immunological process in which antigen fragments are displayed on immune cells to activate CD4+ T helper cells and coordinate the adaptive immune response.
Things worth knowing about "MHC class II presentation"
MHC class II presentation is a key immunological process in which antigen fragments are displayed on immune cells to activate CD4+ T helper cells and coordinate the adaptive immune response.
What is MHC Class II Presentation?
MHC class II presentation is a fundamental mechanism of the adaptive immune system. MHC stands for Major Histocompatibility Complex. MHC class II molecules are specialized surface proteins found on certain immune cells. They display short peptide fragments derived from extracellular pathogens or foreign proteins, thereby alerting the immune system to the presence of an antigen and triggering a targeted immune response.
Which Cells Are Involved?
MHC class II molecules are expressed exclusively on professional antigen-presenting cells (APCs), which include:
- Dendritic cells – the most potent APCs, which patrol tissues throughout the body
- Macrophages – phagocytic cells that engulf and digest pathogens
- B lymphocytes – immune cells that later produce antibodies
These cells take up extracellular antigens (known as exogenous antigens) via phagocytosis or endocytosis, break them down into short peptide fragments, and load them onto MHC class II molecules before transporting the complex to the cell surface.
Mechanism of MHC Class II Presentation
The MHC class II presentation pathway involves several distinct steps:
1. Antigen Uptake
The APC engulfs a pathogen or foreign protein through endocytosis. The ingested material is enclosed within an intracellular vesicle called an endosome.
2. Protein Degradation in the Endosome
Proteolytic enzymes within the endosome degrade the antigen into short peptide chains, typically 13 to 25 amino acids in length. This process is referred to as lysosomal processing.
3. Peptide Loading onto MHC Class II Molecules
MHC class II molecules are synthesized in the endoplasmic reticulum and initially protected from premature peptide loading by a protein called the invariant chain (Ii). Once the endosome fuses with the MHC-II-containing vesicle, the invariant chain is degraded, and an antigenic peptide binds to the groove of the MHC class II molecule. The chaperone molecule HLA-DM facilitates this process by ensuring stable and high-affinity peptide binding.
4. Transport to the Cell Surface
The completed MHC class II-peptide complex is transported to the cell surface, where it is displayed for recognition by T cells.
Activation of T Helper Cells
The peptide-MHC class II complex on the surface of an APC is recognized by the T cell receptor (TCR) of a CD4+ T helper cell. The CD4 co-receptor on the T cell simultaneously binds to the MHC class II molecule, stabilizing the interaction. Full T cell activation also requires co-stimulatory signals, such as the interaction between CD80/CD86 on the APC and CD28 on the T cell.
Once fully activated, T helper cells perform a range of critical immune functions:
- Supporting B cells in antibody production
- Activating cytotoxic T cells
- Stimulating macrophages to enhance pathogen killing
- Releasing cytokines that recruit additional immune cells to the site of infection
MHC Class II and Autoimmune Diseases
Specific variants of MHC class II genes (referred to in humans as HLA class II genes) are associated with an increased susceptibility to autoimmune diseases. When the immune system erroneously recognizes self-derived peptides as foreign and mounts an immune response, conditions such as type 1 diabetes, rheumatoid arthritis, or multiple sclerosis can develop. Research into MHC class II presentation pathways is therefore critical for understanding and treating these conditions.
Clinical Relevance
Understanding MHC class II presentation has important clinical applications across several fields:
- Transplant medicine: Matching HLA class II profiles between donor and recipient significantly reduces the risk of graft rejection.
- Vaccine development: Modern vaccines and immunotherapies are designed to deliberately trigger MHC class II-mediated T helper cell responses.
- Cancer immunotherapy: Tumor antigens can be presented via MHC class II molecules, opening new avenues for therapeutic intervention.
References
- Murphy K, Weaver C. Janeway's Immunobiology. 9th ed. Garland Science; 2017.
- Abbas AK, Lichtman AH, Pillai S. Cellular and Molecular Immunology. 10th ed. Elsevier; 2022.
- Roche PA, Furuta K. The ins and outs of MHC class II-mediated antigen processing and presentation. Nature Reviews Immunology. 2015;15(4):203-216.
Building Blocks for a Healthy Life
As an integrated manufacturer, we develop & produce evidence-based, patented, and non-patented formulations. We work exclusively with plant and natural extracts according to the strictest purity & quality standards.
The combination of science & modern technology with the laws of nature creates solutions consistently tailored to humans – for the highest good: health.
Verwandte Produkte
For Healthy Oral Flora & Dental Care
Formulated lozenges with Dentalac®, lactic acid bacteria, and Lactoferrin CLN®
For your universal protection
As one of the most valuable proteins in the body, lactoferrin is a natural component of the immune system.
For your iron balance
Specially formulated for your iron balance with plant-based curry leaf iron, Lactoferrin CLN®, and natural Vitamin C from rose hips.